海泰科(301022.SZ):目前公司已有完善的報價體系
格隆匯7月26日丨海泰科(301022.SZ)近期在接待機構投資者調研時表示,公司主要產品為注塑模具。公司採用“以銷定產”的生產模式。但由於模具為非標準化定製產品,產品因客户的需求而存在較大差異,導致產品設計結構、加工工序及複雜程度、加工時間各不相同,單件產品生產所需耗用的時間、佔用的設備及人員也存在較大的差異,因此,不同模具的單位售價差異較大。目前公司已有完善的報價體系,具有所銷售產品的完整銷售定價權,定價方式為成本加合理的利潤。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.